Pharma News

Early vs Late Tracheotomy May Not Lower Ventilator-Associated Pneumonia Risk

April 20, 2010 — Early vs late tracheotomy (6 - 8 days vs 13 - 15 days after mechanical ventilation) may not significantly lower the risk for ventilator-associated pneumonia in adult patients in the intensive care unit (ICU), according to the results of a randomized controlled trial reported in the April 21 issue of the Journal of the American Medical Association.

CDC Report Confirms Pregnant Women at Increased Risk for H1N1 Death

Pregnant women infected with the 2009 influenza A (H1N1) virus are at increased risk for death compared with others, but treatment within 2 days of symptom onset decreased this risk, according to a study by the Centers for Disease Control and Prevention (CDC), published in the April 21 issue of the Journal of the American Medical Association.

Celgene forms strategic collaboration with Agios to advance unique science of cancer metabolism

Celgene Corporation and Agios Pharmaceuticals Inc, a privately-held biotechnology company, announced the formation of a global strategic collaboration focused on targeting cancer metabolism. The goal of the collaboration is to discover, develop, and deliver novel disease-altering therapies in oncology based on the transformational science of Agios' innovative cancer metabolism research platform. This platform is based on the concept that targeting key metabolic enzymes unique to rapidly proliferating cancer cells can "starve" the cancer.

Institute for Ageing of New Castle university identifies molecular pathway that reacts to cell damage

Scientists from the Newcastle University’s Institute for Ageing and Health in North East England have identified a molecular pathway which reacts to cell damage and stems the cell’s ability to divide. The experts have used state-of-the-art laboratory techniques and sophisticated mathematical modelling to help crack the problem of cell ageing.

Chennai hosts IIFT seminar to boost export potential of Ayush products

The Indian Institute of Foreign Trade, a deemed university under the Ministry of Commerce, as part of its research study on ‘India’s Export Potential of Ayush Products with SAARC and ASEAN Countries’, held a seminar of exporters of Ayush products in Chennai, yesterday.

The meeting will be held at the Seminar Hall of IMPCOPS at Thiruvanmiyur in the afternoon. IIFT has been commissioned to carry out the research study by the Department of Ayush.

Experimental immune system drug worsens TB in mice

An experimental drug that boosts production of the immune system protein interferon worsens tuberculosis (TB) in mice, according to scientists from the National Institutes of Health (NIH). The drug acts indirectly by drawing certain immune cells, in which Mycobacterium tuberculosis (M.tb) bacteria thrive, to the lungs. The findings may have potential implications for the care of people infected with TB, the authors note. The research is reported in the May 3 issue of Journal of Clinical Investigation, now available online.

Western Ghats Task Force Board increases more Medicinal Plants Conservation Areas in Karnataka

Western Ghats Task Force Board has now designated Medicinal Plants Conservation Areas (MPCAs) in more number of locations in the State. The plan of action is to have one MPCA in every district. The matter is being taken ahead in consultation with the Bangalore-based Foundation for Revitalization of Local Health Traditions (FRLHT). A meeting of scientists and officials of the state forest department would be held to discuss the plan of action, said Ananth Hedge Ashisara, chairperson Western Ghats Task Force.